Event Date/Time: Feb 01, 2006
End Date/Time: Feb 03, 2006
Patient registries provide a unique opportunity within the life science industry to acquire real-world data on product performance, quality of life and segmentation. As pharmaceutical companies are conducting Phase IV or post-marketing trials, they often initiate patient registries as a method of collection and aggregation of the massive amount of data collected from participants. One of the key focuses of this program will be assuring that both commercial and medical goals are met through the utilization of the registry. Through utilizing the registry as both a marketing tool as well as examining the scientific results associated with participating in the trial, sponsors will meet the goal of a comprehensive registry. Another issue that will be addressed through this program is creating functional registries that clinicians and patients will utilize to chart their progress and indications. Without ensuring this functionality, there is very little opportunity for a successful trial. Finally, the program will address regulatory concerns related to utilizing a patient registry, in light of both HIPPA regulations as well as evolving FDA regulations impacting the industry.